Multistate medical cannabis operator Trulieve Cannabis Corp. announced last week that the company expects to begin trading on the New York Stock Exchange (NYSE) under the symbol “TRLV” beginning June 10, 2026.

The announcement follows the rescheduling of state legal medical cannabis from Schedule I to Schedule III under federal law, creating new legal avenues and opportunities for state-licensed medical cannabis companies.

“As the first U.S. cannabis company to list on a major U.S. stock exchange, we are excited about the opportunity to expand our shareholder base, increase liquidity and increase awareness of the benefits of medical marijuana. President Trump’s sensible action to reclassify medical marijuana to Schedule III paved the way for this milestone. The NYSE is a major breakthrough and great progress for the NYSE industry.” – Kim Rivers, Founder and CEO of Trulieve, in a statement

Trulieve operates state-licensed cannabis businesses in Florida, Georgia, Pennsylvania and West Virginia.

The multi-state operator is listing on the NYSE after previously listing on the Canadian Securities Exchange (CSE) under the symbol “TRUL” and the OTCQX under the symbol “TCNNF”.

Trulieve donated heavily to Florida’s failed 2024 cannabis legalization, bringing over $140 million to the effort. The company also contributed $19.6 million to the unsuccessful 2026 campaign bid.

The 24% wholesale tax on cannabis, passed last year by Michigan lawmakers, generated far less revenue in its first quarter than anticipated. The Detroit News reports.

Lawmakers drafted legislation to fund road construction and repairs in the state, and the nonpartisan House Fiscal Agency estimated the 24% wholesale tax would generate about $420 million a year. The state received less than $34 million in the first few months of the new tax, less than a third of quarterly expectations.

Michigan Cannabis Industry Association (MICIA) argued last year that the wholesale tax was unconstitutionally messing with the cannabis framework approved by voters, but the courts refused to block the tax from taking effect on January 1.

“Our elected leaders made the cannabis industry a sacrificial lamb to have the illusion of a road funding fix,” MICIA executive director Robin Schneider said in the report.

“In reality, the only thing they’ve accomplished is the destruction of a strong industry that served as an economic driver for this state. The result is closing businesses, losing jobs, and stripping local governments of tax revenue.” – Schneider, via The Detroit News

The trade group presented a the second lawsuit challenging the wholesale tax on cannabis in March.

Minnesota Gov. Tim Walz (D) last week signed the bill into law reorganization of legislation State cannabis supply chains for medical and adult use.

The law eliminates the state’s current combined medical and adult-use license, sets a new plant cover cap of 38,000 square feet for indoor cultivation — up from a maximum of 90,000 square feet for combined licenses — with 60,000 square feet reserved for medical cannabis products. The bill also creates a new cannabis microbusiness license that will be available starting in 2027.

In addition, the legislation allows companies to hold business licenses for hemp and cannabis. In one STATEMENTState Rep. Nolan West (R) called the previous regulations “absolutely brutal” to businesses and that the bill would fix the “deal of problems” in the state’s cannabis market and open it up so the state “has a thriving market that’s not dominated by just a few players.”

Additionally, the legislation requires the Office of Cannabis Management to conduct a feasibility study to explore a psilocybin therapeutic program. The report on that study is due by January 15, 2027.